{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:17:43Z","timestamp":1792840663967,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/26\/2019 \/ NCD -III"],"award-info":[{"award-number":["5\/13\/26\/2019 \/ NCD -III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000312","name":"Joseph Rowntree Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022756","name":"Centre for Human Drug Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.111921","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T08:42:05Z","timestamp":1711528925000},"page":"111921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1\u03b2 and modulating immunosuppressive response in OSCC"],"prefix":"10.1016","volume":"132","author":[{"given":"Ashutosh","family":"Mahale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Routholla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lavanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3425-2439","authenticated-orcid":false,"given":"Balaram","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onkar Prakash","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.intimp.2024.111921_b0005","first-page":"11884","article-title":"Essentials of oral cancer","volume":"8","author":"Rivera","year":"2015","journal-title":"Int. J. Clin. Exp. Path."},{"key":"10.1016\/j.intimp.2024.111921_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656364","article-title":"Aspects of the tumor microenvironment involved in immune resistance and drug resistance","volume":"12","author":"Khalaf","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111921_b0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2024.111921_b0020","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/948098","article-title":"Macrophages in tumor microenvironments and the progression of tumors","volume":"2012","author":"Hao","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.intimp.2024.111921_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.611115","article-title":"The role of macrophages in Oral squamous cell carcinoma","volume":"11","author":"Kalogirou","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111921_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229089","article-title":"Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma","volume":"15","author":"Pang","year":"2020","journal-title":"PLoSOne"},{"issue":"12","key":"10.1016\/j.intimp.2024.111921_b0035","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.4049\/jimmunol.175.12.8200","article-title":"CD11b+\/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells","volume":"175","author":"Song","year":"2005","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.111921_b0040","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/eji.201041037","article-title":"IL-1\u03b2 regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function","volume":"40","author":"Elkabets","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.111921_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.607209","article-title":"Tumor-associated macrophages in pancreatic ductal adenocarcinoma: origin, polarization, function, and reprogramming","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2024.111921_b0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopha.2018.07.114","article-title":"Preventive measures in oral cancer: an overview","volume":"107","author":"D'souza","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2024.111921_b0055","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.4317\/medoral.17323","article-title":"Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer","volume":"17","author":"Brailo","year":"2012","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.intimp.2024.111921_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2021.649406","article-title":"Expression of interleukin-1\u00df and Interleukin-8 in Oral potentially malignant disorders and carcinomas","volume":"2","author":"Lopez-Labady","year":"2021","journal-title":"Front Oral Health."},{"issue":"2","key":"10.1016\/j.intimp.2024.111921_b0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cyto.2013.08.011","article-title":"Interleukin-1 beta in unstimulated whole saliva is a potential biomarker for oral squamous cell carcinoma","volume":"64","author":"Kamatani","year":"2013","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.intimp.2024.111921_b0070","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12967-021-03181-x","article-title":"Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.111921_b0075","first-page":"1329","article-title":"TRAP1 suppresses oral squamous cell carcinoma progression by reducing oxidative phosphorylation metabolism of cancer-associated fibroblasts BMC","volume":"21","author":"Xiao","year":"2021","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2024.111921_b0080","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3390\/cancers12071791","article-title":"Interleukin-1\u03b2 and cancer","volume":"12","author":"R\u00e9b\u00e9","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.intimp.2024.111921_b0085","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/cas.14135","article-title":"Cancer-associated fibroblast-derived interleukin-1\u03b2 activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer","volume":"110","author":"Huang","year":"2019","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.111921_b0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.intimp.2024.111921_b0095","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood-2006-03-014126","article-title":"Histone deacetylase inhibitors prevent exocytosis of interleukin-1beta-containing secretory lysosomes: role of microtubules","volume":"108","author":"Carta","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2024.111921_b0100","doi-asserted-by":"crossref","first-page":"11547","DOI":"10.1038\/s41598-017-11739-3","article-title":"Human histone deacetylase 6 shows a strong preference for tubulin dimers over assembled microtubules","volume":"7","author":"Skultetyova","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2024.111921_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165903","article-title":"HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1\u03b2 secretion in diabetic mice","volume":"1866","author":"Karnam","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.111921_b0110","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1038\/s41598-020-64494-3","article-title":"Validation of salivary markers, IL-1\u03b2, IL-8 and Lgals3bp for detection of oral squamous cell carcinoma in an Indian population","volume":"10","author":"Singh","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2024.111921_b0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/imm.13486","article-title":"Pathogenetic role and clinical significance of interleukin-1\u03b2 in cancer","volume":"168","author":"Malkova","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2024.111921_b0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/BIC.S25375","article-title":"Interleukin 1\u03b2-a potential salivary biomarker for cancer progression?","volume":"7","author":"Idris","year":"2015","journal-title":"Biomark Cancer."},{"issue":"4","key":"10.1016\/j.intimp.2024.111921_b0125","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/jcp.24816","article-title":"IL-1\u03b2 promotes malignant transformation and tumor aggressiveness in oral cancer","volume":"230","author":"Lee","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.intimp.2024.111921_b0130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-018-0788-2","article-title":"Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d\/PI3K\/AKT\/mTOR and ERK pathways","volume":"9","author":"Cao","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.111921_b0135","first-page":"117","article-title":"Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma","volume":"29","author":"Sakuma","year":"2006","journal-title":"Int. J. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2024.111921_b0140","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.oraloncology.2015.04.010","article-title":"miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6","volume":"51","author":"Wang","year":"2015","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111921_b0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","article-title":"HDAC6 modulates cell motility by altering the acetylation level of cortactin","volume":"27","author":"Zhang","year":"2007","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.intimp.2024.111921_b0150","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.4049\/jimmunol.1300354","article-title":"Lipopolysaccharide stimulates platelets through an IL-1\u03b2 autocrine loop","volume":"191","author":"Brown","year":"2013","journal-title":"J. Immunol."},{"issue":"27","key":"10.1016\/j.intimp.2024.111921_b0155","doi-asserted-by":"crossref","first-page":"24424","DOI":"10.18632\/oncotarget.4420","article-title":"Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.intimp.2024.111921_b0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3892\/br.2016.583","article-title":"4-Nitroquinoline-1-oxide affects human lung adenocarcinoma A549 cells by regulating the expression of POLD4","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed Rep."},{"key":"10.1016\/j.intimp.2024.111921_b0165","doi-asserted-by":"crossref","unstructured":"T. Alkasalias, L. Moyano-Galceran, M. Arsenian-Henriksson, K. Lehti, Fibroblasts in the tumor microenvironment: Shield or spear?, Int. J. Mol. Sci., 19(5) (May 21, 2018). MDPI AG,. doi: 10.3390\/ijms19051532.","DOI":"10.3390\/ijms19051532"},{"issue":"15","key":"10.1016\/j.intimp.2024.111921_b0170","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.yexcr.2011.05.023","article-title":"Tumor-produced, active Interleukin-1 \u03b2 regulates gene expression in carcinoma-associated fibroblasts","volume":"317","author":"Dud\u00e1s","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2024.111921_b0175","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1038\/s41388-018-0379-9","article-title":"Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3\u2013COX2-dependent pathway","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2024.111921_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108919","article-title":"HDAC6 inhibition attenuates renal injury by reducing IL-1\u03b2 secretion and RIP kinase mediated necroptosis in acute oxalate nephropathy","volume":"110","author":"Sedmaki","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111921_b0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12105-013-0476-6","article-title":"Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck","volume":"8","author":"Saba","year":"2014","journal-title":"Head Neck Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111921_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229089","article-title":"Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma","volume":"15","author":"Pang","year":"2020","journal-title":"PLoS One."},{"key":"10.1016\/j.intimp.2024.111921_b0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.oraloncology.2019.06.004","article-title":"Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma","volume":"95","author":"Zhong","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.intimp.2024.111921_b0200","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fimmu.2020.01371","article-title":"Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.111921_b0205","doi-asserted-by":"crossref","first-page":"1160719","DOI":"10.3389\/fimmu.2023.1160719","article-title":"Advances in the role of STAT3 in macrophage polarization","volume":"14","author":"Xia","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.111921_b0210","article-title":"Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge","author":"Petruzzi","year":"201712132","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111921_b0215","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1038\/s41598-022-14052-w","article-title":"HDAC6 is a prognostic biomarker that mediates IL-13 expression to regulate macrophage polarisation through AP-1 in oral squamous cell carcinoma","volume":"12","author":"Tseng","year":"2022","journal-title":"Sci. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924004399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924004399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:52:28Z","timestamp":1778820748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924004399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":43,"alternative-id":["S1567576924004399"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111921","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1\u03b2 and modulating immunosuppressive response in OSCC","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111921"}}